Navigating FDA Compliance in Healthcare PM Interviews

TL;DR

Most healthcare PM candidates fail not because they lack product sense, but because they treat FDA compliance as a checklist item instead of a product strategy lever. The distinction isn’t regulatory knowledge versus execution—it’s whether you can align clinical risk with roadmap trade-offs in real time. If your interview stories don’t show how you’ve used FDA pathways to enable speed, not just survive audits, you’ll be filtered out.

Who This Is For

This is for product managers with 3–8 years of experience transitioning into healthcare or medtech from B2B SaaS, fintech, or consumer tech, and who are preparing for PM roles at companies like Medtronic, Ro, Tempus, or Omada Health—where FDA-regulated software (SaMD), diagnostics, or combination products are core to the business model. It’s also for internal candidates at healthcare startups who’ve avoided compliance discussions until interview season.

Why do interviewers care about FDA knowledge in healthcare PM roles?

They don’t care about your ability to recite 21 CFR Part 820. They care whether you prioritize features with clinical risk in mind. In a Q3 interview loop at a digital therapeutics startup, the hiring manager killed an otherwise strong candidate’s packet because the debrief showed “zero mention of design controls when discussing a feature that triggered a Class II submission.” The oversight wasn’t ignorance—it was the signal that their product judgment didn’t scale to regulated environments.

Regulated products change the cost of failure. A bug in a consumer app loses DAUs. A bug in an insulin dosing algorithm risks FDA Form 483s and market withdrawal. Interviewers probe FDA awareness not for trivia, but to test risk-calibrated decision-making.

Not “Do you know what a 510(k) is?” but “Can you trade off speed and safety when the VP of Engineering says we can ship with a design flaw if we label around it?” That’s the real question.

In one debrief at a connected device company, the hiring committee approved a candidate who admitted they’d never filed a 510(k), but correctly argued for delaying a UI launch because it obscured a critical alarm state—citing human factors validation requirements from IEC 62366. Judgment trumped experience.

How do healthcare PM interviews test FDA compliance knowledge?

They embed it in behavioral and case questions, never as standalone quizzes. At Johnson & Johnson’s digital surgery division, the PM interview includes a live scenario: “You’re six weeks from launch. QA flags inconsistent log entries in your surgical planning tool. Do you ship?” The expected answer isn’t “consult regulatory” — that’s table stakes. The differentiator is whether you frame the decision using potential for patient harm and traceability to design inputs, not just timelines.

Interviewers use four formats:

Behavioral questions about past product decisions involving risk evaluation
Live case exercises with simulated audit findings
Roadmap prioritization under compliance constraints
Stakeholder roleplays (e.g., “Convince your CFO to delay launch for a minor labeling issue”)

At a recent Ro interview, candidates were given a mock EHR integration project and asked to build a release plan. One candidate lost points by scheduling “post-launch usability testing.” The panel noted, “You can’t retrofit human factors validation. That’s not agile—it’s noncompliant.” Speed is not an excuse for skipping design verification.

Not “Can you follow process?” but “Can you lead through it when others cut corners?” That’s the subtext.

What FDA frameworks should healthcare PMs actually know?

You need working fluency in five:

Quality System Regulation (QSR / 21 CFR Part 820) – especially design controls (820.30)
Software as a Medical Device (SaMD) framework from IMDRF
IEC 62304 – software lifecycle for medical devices
IEC 62366-1 – usability engineering
21 CFR Part 11 – electronic records and signatures

These aren’t memorization targets. They’re decision-making scaffolds. In a debrief at a mental health SaMD company, a candidate was praised for using IEC 62304’s software safety classification (Class A/B/C) to justify skipping a full regression test—because the change was in a non-critical module. That showed integration, not recitation.

The trap is treating these like law school exams. Hiring managers don’t want paralegals. They want PMs who use standards to enable innovation. For example, using the FDA’s Breakthrough Devices Program to compress clinical validation timelines is strategic—not compliance, but competitive advantage.

Not “Are you compliant?” but “How does compliance reduce your time to value?” That’s the lens.

In a Google Health debrief last year, the committee favored a candidate who redesigned a diabetic retinopathy screening workflow to satisfy both FDA submission requirements and clinician adoption—by aligning training data collection with clinical study design. The insight: regulatory evidence can double as go-to-market proof.

How to structure behavioral answers involving FDA or risk?

Use the HARM framework: Hazard, Action, Risk Mitigation, Metrics. Never lead with process. Lead with patient impact.

BAD: “We followed design controls and filed a 510(k).”

GOOD: “We identified a hazard—misleading UI in low-light conditions for a handheld diagnostic—so we paused release, ran usability testing per 62366, and reduced use errors from 12% to 2% before submission.”

In a Philips interview, a candidate described fixing a bug in firmware update logic. Their original answer was technical: “We issued a patch.” After coaching, they rephrased: “We classified the risk as moderate (IEC 62304 Class B), initiated a recall-level review, and pushed the fix through verified channels to avoid bricking devices. No patient events occurred.” The revised answer showed judgment hierarchy—clinical impact first, code second.

Interviewers assess whether you own risk or delegate it. Saying “regulatory advised us” is neutral. Saying “I escalated because the risk profile crossed into Class II” shows ownership.

Not “What you did,” but “How you weighed consequences.” That’s the signal.

Preparation Checklist

Map your past product decisions to FDA-relevant risk categories (e.g., data integrity, usability, algorithm bias)
Practice framing trade-offs using safety classifications (IEC 62304) and design control phases (input → output → verification)
Prepare 2-3 stories where you proactively identified a potential regulatory issue before launch
Study real FDA warning letters (search FDA’s database for “software,” “UI error,” “validation”)—they’re goldmines for interview scenarios
Work through a structured preparation system (the PM Interview Playbook covers SaMD case frameworks and real debrief examples from J&J, Omada, and Ro)
Run mock interviews with PMs who’ve shipped FDA-regulated products—ideally with combination devices or AI/ML components
Internalize the difference between compliance (meeting requirements) and assurance (building systems that prevent failures)

Mistakes to Avoid

BAD: “We moved fast and fixed bugs post-launch. It worked out.”
GOOD: “We classified the feature as SaMD Class B, so we front-loaded usability testing and only enabled gradual rollout with audit logging. Zero use errors in first 90 days.”

Explanation: In regulated domains, “move fast” is a red flag. Speed must be risk-managed, not celebrated. Companies get burned by PMs who bring consumer-grade agility into clinical environments.

BAD: “I collaborated with regulatory to submit a 510(k).”
GOOD: “I led a cross-functional team to align design inputs with FDA guidance DG-2021-012, reducing submission cycles from three to one by pre-answering reviewer questions.”

Explanation: “Collaborated” is passive. Hiring managers want PMs who drive submissions, not support them. Regulatory teams are advisors. The PM owns the evidence package.

BAD: “Our product didn’t require FDA approval.”
GOOD: “We assessed against FDA’s enforcement discretion policy for low-risk general wellness tools, but still applied design controls to build audit readiness in case the scope changed.”

Explanation: Many candidates hide behind “we’re not regulated.” That’s a missed opportunity. Showing proactive rigor—even when optional—signals maturity. In a Verily interview, a candidate won points by applying design history file (DHF) practices to a research tool that wasn’t FDA-bound. The panel said, “They think like a regulated product leader.”

FAQ

Do I need FDA experience to land a healthcare PM role?

No. But you must demonstrate risk-aware product judgment. Candidates without direct experience succeed when they reframe past work through clinical impact—e.g., treating PII breaches as potential HIPAA/FDA crossover risks, or applying validation principles to A/B tests. The gap isn’t knowledge—it’s framing.

How deep should I go on regulations like 21 CFR Part 11 or IEC 62366?

Know enough to apply them in decisions, not recite them. For Part 11, understand that electronic signatures require audit trails and user authentication—not that it’s “Subpart B.” For 62366, know that usability testing must reflect real-world conditions, not just lab settings. Depth is measured by application, not memorization.

What if I’ve only worked on non-regulated health products?

Translate your rigor. If you’ve built EHR integrations, emphasize data validation and clinician workflows. If you’ve done chronic care apps, focus on user safety (e.g., medication reminders). In a Teladoc interview, a candidate with fitness app experience won by discussing how they stress-tested alert logic to avoid harmful delays—framing it as “self-imposed design control.” Context is malleable; judgment is not.

What are the most common interview mistakes?

Three frequent mistakes: diving into answers without a clear framework, neglecting data-driven arguments, and giving generic behavioral responses. Every answer should have clear structure and specific examples.

Any tips for salary negotiation?

Multiple competing offers are your strongest leverage. Research market rates, prepare data to support your expectations, and negotiate on total compensation — base, RSU, sign-on bonus, and level — not just one dimension.

Ready to build a real interview prep system?

Get the full PM Interview Prep System →

The book is also available on Amazon Kindle.